Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q7VI
|
|||
| Former ID |
DIB011233
|
|||
| Drug Name |
Siguazodan
|
|||
| Synonyms |
SKF-94836
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Allergy [ICD-11: 4A80-4A85; ICD-10: T78.4; ICD-9: 995.3] | Terminated | [1] | |
| Company |
SmithKline Beecham plc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H16N6O
|
|||
| Canonical SMILES |
CC1CC(=O)NN=C1C2=CC=C(C=C2)NC(=NC)NC#N
|
|||
| InChI |
1S/C14H16N6O/c1-9-7-12(21)19-20-13(9)10-3-5-11(6-4-10)18-14(16-2)17-8-15/h3-6,9H,7H2,1-2H3,(H,19,21)(H2,16,17,18)
|
|||
| InChIKey |
NUHPODZZKHQQET-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 115344-47-3
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:91791
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Phosphodiesterase 3 (PDE3) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000375) | |||
| REF 2 | Cyclic-AMP-dependent proliferation of a human osteoblast cell line (HOS cells) induced by hydroxyapatite: effect of exogenous nitric oxide. Acta Biomed. 2008 Aug;79(2):110-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.